Company introduces 'gene writing', to surpass CRISPR's limitations
Wired - 07-Jul-2020New class of gene editors set to remove hurdles of traditional gene therapy
Geoffrey von Maltzahn
CEO, Tessera Therapeutics
Geoffrey von Maltzahn, Ph.D. is an American biological engineer and entrepreneur in biotechnology and life sciences industry who has founded a number of companies including Indigo Agriculture, Kaleido Biosciences, Seres Therapeutics, Axcella Health and Sienna Biopharmaceuticals.
Visit website: https://www.flagshippioneering.com/people/geoffrey-von-maltzahn
geoffrey-von-maltzahn-7a6b755a
See also: 
Tessera Therapeutics
- Genetic medicine company
Details last updated 24-Jul-2020
Geoffrey von Maltzahn News
